Cover Image
市場調查報告書

Avaxia Biologics, Inc. 的產品平台分析

Avaxia Biologics, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226300
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Avaxia Biologics, Inc. 的產品平台分析 Avaxia Biologics, Inc. - Product Pipeline Review - 2015
出版日期: 2015年05月13日 內容資訊: 英文 23 Pages
簡介

Avaxia Biologics, Inc.是ha美國的製藥企業,正在開發以消化道疾病為標的抗體治療藥。

本報告提供Avaxia Biologics, Inc. 的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Avaxia Biologics, Inc. 概要

  • 公司概要
  • 主要資訊
  • 企業資料

Avaxia Biologics, Inc. :R&D概要

  • 主要的治療範圍

Avaxia Biologics, Inc. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Avaxia Biologics, Inc. :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Avaxia Biologics, Inc. :藥物簡介

  • AVX-470
  • AVX-176
  • Antibody for Obesity and Type II Diabetes

Avaxia Biologics, Inc. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Avaxia Biologics, Inc. :最近的開發平台趨勢

Avaxia Biologics, Inc. :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07086CDB

Summary

Global Markets Direct's, 'Avaxia Biologics, Inc. - Product Pipeline Review - 2015', provides an overview of the Avaxia Biologics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Avaxia Biologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Avaxia Biologics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Avaxia Biologics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Avaxia Biologics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Avaxia Biologics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Avaxia Biologics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Avaxia Biologics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Avaxia Biologics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Avaxia Biologics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Avaxia Biologics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Avaxia Biologics, Inc. Snapshot
    • Avaxia Biologics, Inc. Overview
    • Key Information
    • Key Facts
  • Avaxia Biologics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Avaxia Biologics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Avaxia Biologics, Inc. - Pipeline Products Glance
    • Avaxia Biologics, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Avaxia Biologics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Avaxia Biologics, Inc. - Drug Profiles
    • AVX-470
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AVX-176
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Antibody for Obesity and Type II Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Avaxia Biologics, Inc. - Pipeline Analysis
    • Avaxia Biologics, Inc. - Pipeline Products by Target
    • Avaxia Biologics, Inc. - Pipeline Products by Route of Administration
    • Avaxia Biologics, Inc. - Pipeline Products by Molecule Type
    • Avaxia Biologics, Inc. - Pipeline Products by Mechanism of Action
  • Avaxia Biologics, Inc. - Recent Pipeline Updates
  • Avaxia Biologics, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Avaxia Biologics, Inc., Key Information
  • Avaxia Biologics, Inc., Key Facts
  • Avaxia Biologics, Inc. - Pipeline by Indication, 2015
  • Avaxia Biologics, Inc. - Pipeline by Stage of Development, 2015
  • Avaxia Biologics, Inc. - Monotherapy Products in Pipeline, 2015
  • Avaxia Biologics, Inc. - Phase I, 2015
  • Avaxia Biologics, Inc. - Preclinical, 2015
  • Avaxia Biologics, Inc. - Discovery, 2015
  • Avaxia Biologics, Inc. - Pipeline by Target, 2015
  • Avaxia Biologics, Inc. - Pipeline by Route of Administration, 2015
  • Avaxia Biologics, Inc. - Pipeline by Molecule Type, 2015
  • Avaxia Biologics, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Avaxia Biologics, Inc. - Recent Pipeline Updates, 2015

List of Figures

  • Avaxia Biologics, Inc. - Pipeline by Top 10 Indication, 2015
  • Avaxia Biologics, Inc. - Pipeline by Stage of Development, 2015
  • Avaxia Biologics, Inc. - Monotherapy Products in Pipeline, 2015
  • Avaxia Biologics, Inc. - Pipeline by Top 10 Target, 2015
  • Avaxia Biologics, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Avaxia Biologics, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Avaxia Biologics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top